[1] Younis BB, Arshad R, Khurhsid S, et al.Fulminant hepatic failure (FHF) due to acute hepatitis C[J]. Pak J Med Sci, 2015, 31(4):1009-1011. [2] Kirnap M, Akdur A, Ozcay F, et al.Liver transplant for fulminant hepatic failure: a single-center experience[J]. Exp Clin Transplant, 2015, 13(4):339-343. [3] Stadelmann VA, Potapova I, Camenisch K, et al.In vivo microCT monitoring of osteomyelitis in a rat model[J]. Biomed Res Int, 2015, 2015:587857. [4] Lalwani K, Giddabasappa A, Li D, et al.Contrast agents for quantitative microCT of lung tumors in mice[J]. Comp Med, 2013, 63(6):482-490. [5] Thurman JM, Rohrer B.Noninvasive detection of complement activation through radiologic imaging[J]. Adv Exp Med Biol, 2013, 735:271-282. [6] Saito S, Murase K.Detection and early phase assessment of radiation-induced lung injury in mice using micro-CT[J]. PLoS One, 2012, 7(9):e45960. [7] Wang X, Hagemeyer CE, Hohmann JD, et al.Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice[J]. Circulation, 2012, 125(25):3117-3126. [8] Kuroda H, Kakisaka K, Kamiyama N, et al.Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude[J]. World J Gastroenterol, 2012, 18(29):3889-3895. [9] Hyafil F, Cornily JC, Feig JE, et al.Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography[J]. Nat Med, 2007, 13(5):636-641. [10] Weichert JP, Longino MA, Bakan DA, et al.Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver[J]. J Med Chem, 1995, 38(4):636-646. [11] Bakan DA, Doerr-Stevens JK, Weichert JP, et al.Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride for contrast-enhanced computed tomography[J]. Am J Ther, 2001, 8(5):359-365. [12] Willekens I, Lahoutte T, Buls N, et al.Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC[J]. Mol Imaging Biol, 2009, 11(2):128-135. [13] Boll H, Figueiredo G, Fiebig T, et al.Com〈parison of Fenestra LC, ExiTron nano 6000, and ExiTron nano 12000 for micro-CT imaging of liver and spleen in mice[J]. Acad Radiol, 2013, 20(9):1137-1143. [14] Ding J, Wang Y, Ma M, et al.CT/fluorescence dual-modal nanoemulsion platform for investigating atherosclerotic plaques[J]. Biomaterials, 2013, 34(1):209-216. [15] Chen W, Vucic E, Leupold E, et al.Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis[J]. Contrast Media Mol Imaging, 2008, 3(6): 233-242. [16] Liu LM, Zhang JX, Luo J, et al.A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats[J]. Dig Dis Sci, 2008, 53(5):1316-1324. [17] Zhang S, Yang N, Ni S, et al.Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway[J]. Int J Clin Exp Pathol, 2014, 7(10):6626-6634. [18] Chastre A, Belanger M, Beauchesne E, et al.Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications[J]. PLoS One, 2012, 7(11):e49670. [19] Inoue K, Takano H, Satoh M.Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN[J]. Thromb Haemost, 2008, 99(5):980-983. [20] Ahmad A, Raish M, Ganaie MA, et al.Hepatoprotective effect of Commiphora myrrha against d-GalN/LPS-induced hepatic injury in a rat model through attenuation of pro inflammatory cytokines and related genes[J]. Pharm Biol, 2015, 53(12):1759-1767. [21] Liu H, Zhang W, Dong S, et al.Protective effects of Sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-kappaB signaling[J]. J Ethnopharmacol, 2015, 176:69-78. [22] Streetz K, Leifeld L, Grundmann D, et al.Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure[J]. Gastroenterology, 2000, 119(2):446-460. |